Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

344 search results for ‘*’

Business & Regulation Profession

The Start of a Journey

| Stephanie Vine | 6 min read

Meet Brad Hocking – a final year PhD student at Imperial College London who is passionate about small molecule drug discovery.

Business & Regulation Profession

Let’s Talk About Talent

| Stephanie Vine | 12 min read

We speak with Vertex Pharmaceuticals about internships and co-ops in the industry for young talent.

Manufacture Quality & Compliance

The AMR Certificate

| Jamie Irvine | 5 min read

Introducing the British Standards Institution’s new environmental initiative to minimize antimicrobial resistance caused by manufacturing operations.

Discovery & Development Drug Delivery

Digging into the Dangers

| Jamie Irvine | 5 min read

Research sheds new light on cancer risk in gene therapies

Business & Regulation Trends & Forecasts

Bridging the Gap

| Jamie Irvine | 7 min read

What have we learned from an ever-evolving cell and gene therapy field?

Discovery & Development Drug Discovery

T Cells, Sea Shells and Cancer Cures

| 5 min read

Adrian Baez-Ortega shares on pioneering the genome sequencing of transmissible cancers in cockles – and what this research means for humans.

Discovery & Development Drug Delivery

Taking Vaccines Beyond Borders

| Jamie Irvine | 3 min read

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Manufacture Advanced Medicine

Interviewing Paul Donohoue: A Guiding RNA-DNA Light for CRISPR

| Stephanie Vine | 12 min read

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

Discovery & Development Drug Delivery

Bringing a New MOA to the Table

| Jamie Irvine | 3 min read

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register